目的:本研究旨在确定,评估,并总结有关数字工具的证据,这些工具可以对儿科肿瘤患者进行自我报告的症状评估和管理。
方法:七个学术数据库,包括PubMed,科克伦图书馆,Scopus,WebofScience,CINAHL,和Medline(OVID),从开始到2024年2月28日进行了系统搜索。纳入标准如下:(a)研究对象是儿科肿瘤患者和年轻人,(b)使用数码工具,(c)自我报告症状评估和管理,(d)采用定性或定量研究设计,(e)用英文撰写(f)在同行评审期刊上发表。这是一个系统的回顾,其协议在PROSPERO(ID:CRD42024528285)中注册。这项研究是根据PRISMA声明进行的。
结果:本系统综述包括27项研究。进行所有纳入的研究以开发用于评估和管理症状的数字工具。其中八项研究仅关注疼痛;三项仅针对恶心和呕吐,一个是恶心,其他15种症状。研究质量从低到高,总分在28分中的4到24分之间。
结论:研究表明,研究通常集中在开发数字工具来解决疼痛,恶心,呕吐,以及儿科肿瘤患者常见的其他症状。虽然纳入研究的质量从低到高,总体研究结果表明,这些数字工具在儿科肿瘤治疗中用于症状评估和管理的有效性和可用性有望得到应用.
OBJECTIVE: This study aims to identify, evaluate, and summarize evidence on digital tools that enable self-reported symptom assessment and management for pediatric oncology patients.
METHODS: Seven academic databases, including PubMed, Cochrane Library, Scopus, Web of Science, CINAHL, and Medline (OVID), were searched systematically from inception until February 28, 2024. Inclusion criteria were the following: (a) study subjects were pediatric oncology patients and young adults, (b) using digital tools, (c) self-report symptom assessment and management, (d) employed either qualitative or quantitative study design, (e) written in English (f) published in peer-reviewed journals. This is a systematic review, and its protocol was registered in PROSPERO (ID: CRD42024528285). The study was conducted following the PRISMA statement.
RESULTS: Twenty-seven studies were included in this systematic review. All included studies were conducted to develop digital tools for assessing and managing the symptoms. Eight of these studies focused only on the pain; three were only for nausea and vomiting, one for nausea, and the other 15 for all symptoms. The studies\' quality ranged from low to high, with overall scores ranging between 4 and 24 out of 28.
CONCLUSIONS: It shows that studies have generally focused on developing digital tools to address pain, nausea, vomiting, and other symptoms commonly experienced by pediatric oncology patients. While the quality of the included studies ranged from low to high, the overall findings show promise for the effectiveness and usability of these digital tools for symptom assessment and management in pediatric oncology care.